Molecular mechanim of cytotoxicity induced by dopamine and 6-hydroxydopamine
多巴胺和6-羟基多巴胺诱导细胞毒性的分子机制
基本信息
- 批准号:08670708
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To promote possible neuroprotective strategies for Parkinson's disease, the present study was conducted to clarify differencies in biochemical mechanisms among cytotoxicites of dopamine (DA), levedopa (L-DOPA) and 6-hydroxydopamine (6-OHDA).1. DNA fragmentation induced by iron + hydrogen peroxide was extremely acclererated by DA and L-DOPA.Co-existence of 6-OHDA and zinc produed DNA fragmentation, although zinc alone did not produce DNA fragmentation. Aluminium-induced DNA fragmentation was differntly inhibited by DA-related compounds, indicating that action mechanism of alununium may be differant from those of the other transition metals.2. Production of hydroxyl radicals induced by iron was accelerated by 6-OHDA, although that was not affected by DA or L-DO PA.High production of hydroxyl radicals induced by cupper was suppressed by all DA-related compounds.3. Lipid peroxidation induced by iron was slightly inhibited by DA, but not affected by L-DOPA nor 6-OHDA.On the other hand, copper-induced lipid pereoxidation was extremely inhibited by DA, L-DOPA and 6-OHDA.4. Transition metals, especially copper, showed cytotoxicity against DAeregic neuronal cell line (B65). Among DA-related compounds, 6-OHDA showed cytotoxicity against B65 cells.5. Transition metals and 6-OHDA strongly increased superoxide dismutase (SOD) activities in B65 cells, but L-DOPA increased slightly SOD activities in those cells. Although iron and copper decreased slightly glutathione (GSH) activities, DA and 6-OHDA increased strongly GSH levels in B56 cells.Thus, DA, L-DOPA and 6-OHDA showed different cytotoxicities based on different interactions with transition metals, free radicals and redox states. The present results are useful information for establishing the neuroprotective strategies for Parkinson's disease.
为了促进帕金森氏病的神经保护策略,进行了本研究,以阐明多巴胺(DA),Levedopa(L-Dopa)和6-羟基羟基多巴胺(6-OHDA)的多巴胺(DA)的生化机制的差异。由DA和L-DOPA诱导的DNA片段化极度浓度。6-OHDA的Co存在,锌和锌产生DNA片段化,尽管单独锌并没有产生DNA片段化。铝诱导的DNA片段化被与DA相关的化合物抑制了不同,这表明弹霉的作用机理可能与其他过渡金属的作用机理不同。2。由6-OHDA加速了由铁诱导的羟基自由基的产生,尽管这不受DA或L-DO PA的影响。所有与DA相关的化合物抑制了由Cupper诱导的羟基自由基的产生。3。 DA诱导的铁诱导的脂质过氧化略微抑制,但另一方面不受L-DOPA或6-OHDA的影响,DA,L-DOPA和6-OHDA.4。过渡金属,尤其是铜,表现出针对辅助神经元细胞系的细胞毒性(B65)。在与DA相关的化合物中,6-OHDA对B65细胞显示细胞毒性5。过渡金属和6-OHDA在B65细胞中强烈增加了超氧化物歧化酶(SOD)活性,但是L-DOPA增加了这些细胞中略微SOD活性。尽管铁和铜的略微降低了谷胱甘肽(GSH)的活性,但DA和6-OHDA在B56细胞中的GSH水平强大升高。因此,基于与过渡金属,自由基和氧化还原状态的不同相互作用,DA,L,L-DOPA和6-OHDA显示出不同的细胞毒性。目前的结果是建立帕金森氏病神经保护策略的有用信息。
项目成果
期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Iida,K.: "Effects of repeated cyclosporin A administration on iminodipropionitrile-induced dyskinesia and TRE-/CRE-binding activities in rat brain." Neurosci.Res.30. 185-193 (1998)
Iida,K.:“重复施用环孢素 A 对亚氨基二丙腈诱导的大鼠脑运动障碍和 TRE-/CRE 结合活性的影响。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanaka,K.: "Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion." Brain Res.729. 55-65 (1996)
Tanaka,K.:“慢性脑灌注不足后 Wistar 大鼠胆碱能功能障碍与辨别学习障碍之间的关系。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Aoki, C.et al.: "Stimulatory effects of 4-methylcatechol, dopamine and levodopa on the expression of metallothionein-III (GIF) mRNA in immortalized mouse brain glial cells (VR-2g)." Brain Res.792. 335-339 (1998)
Aoki, C.等人:“4-甲基儿茶酚、多巴胺和左旋多巴对永生化小鼠脑胶质细胞 (VR-2g) 中金属硫蛋白-III (GIF) mRNA 表达的刺激作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Iwata-Ichikawa, E.: "Glial cells protect neuronal cells against oxidative stress via transcriptional up-regulation of the glutathione system." J.Neurochem.(in press).
Iwata-Ichikawa, E.:“神经胶质细胞通过谷胱甘肽系统的转录上调来保护神经元细胞免受氧化应激。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Aoki,C.: "Stimulatory effects of 4-methylcatechol,dopamine and levodopa on the expression of metallothionein-III (GIF) mRNA in immortalized mouse brain glial cells (VR-2g)." Brain Res.792. 335-339 (1998)
Aoki,C.:“4-甲基儿茶酚、多巴胺和左旋多巴对永生化小鼠脑胶质细胞 (VR-2g) 中金属硫蛋白-III (GIF) mRNA 表达的刺激作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OGAWA Norio其他文献
OGAWA Norio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OGAWA Norio', 18)}}的其他基金
Studies on specific genes in the brain induced by DOPA and their function.
多巴诱导的大脑特定基因及其功能的研究。
- 批准号:
14570599 - 财政年份:2002
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular function of metallothionein-III in parkinsonism with drug treatment
金属硫蛋白-III在帕金森病药物治疗中的分子功能
- 批准号:
11670629 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular pathophysiology of dopamine receptors in dyskinesia
运动障碍多巴胺受体的分子病理生理学
- 批准号:
04670489 - 财政年份:1992
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Biochemical and pharmacolotical pathogenesis of dyskinesia in the IDPN-treated rat model
IDPN 治疗的大鼠模型运动障碍的生化和药理学发病机制
- 批准号:
01570449 - 财政年份:1989
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Interactions between Classical Neurotransmitter Systems and Neuropeptide Systems in Experimental Animal Model of Parkinsonism
帕金森病实验动物模型中经典神经递质系统与神经肽系统的相互作用
- 批准号:
61570387 - 财政年份:1986
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
首乌方对L-DOPA诱发异动症模型大鼠的干预作用及其机制研究
- 批准号:81274121
- 批准年份:2012
- 资助金额:16.0 万元
- 项目类别:面上项目
利用宏基因组文库和微生物菌种库构建高效转化制备L-DOPA的酪氨酸酶体系
- 批准号:81102362
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:青年科学基金项目
相似海外基金
L-dopa治療最適化に向けた瞬目を用いた治療デジタルバイオマーカーの確立
使用眨眼建立治疗数字生物标志物以优化左旋多巴治疗
- 批准号:
24K09947 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of Low-Dose Ketamine Treatment for Parkinson's Disease [Diversity Supplement for Raveena Parmar]
低剂量氯胺酮治疗帕金森病的机制 [Raveena Parmar 的多样性补充]
- 批准号:
10740600 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Preclinical development of a novel therapeutic for Parkinson's disease
帕金森病新型疗法的临床前开发
- 批准号:
10913244 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Parkinsons disease scalable iPSC autologous cell therapy
帕金森病可扩展 iPSC 自体细胞疗法
- 批准号:
10877279 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Multi-scale functional connectivity in preclinical models of Parkinson's disease
帕金森病临床前模型的多尺度功能连接
- 批准号:
10543831 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别: